Alerts will be sent to your verified email
Verify Email
FISCHER
|
Fischer Medical
|
India Glycols
|
GHCL
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.29 % | 11.1 % | 21.5 % |
|
5yr average Equity Multiplier
|
0.49 | 2.83 | 1.42 |
|
5yr Average Asset Turnover Ratio
|
0.4 | 0.59 | 0.78 |
|
5yr Avg Net Profit Margin
|
-4.14 % | 6.73 % | 19.59 % |
|
Price to Book
|
17.99 | 2.69 | 1.72 |
|
P/E
|
961.12 | 24.91 | 9.74 |
|
5yr Avg Cash Conversion Cycle
|
140.14 Days | -124.61 Days | 23.8 Days |
|
Inventory Days
|
33.45 Days | 41.61 Days | 79.76 Days |
|
Days Receivable
|
163.11 Days | 15.12 Days | 20.09 Days |
|
Days Payable
|
23.17 Days | 174.74 Days | 78.33 Days |
|
5yr Average Interest Coverage Ratio
|
12.88 | 3.32 | 29.25 |
|
5yr Avg ROCE
|
3.71 % | 8.82 % | 22.74 % |
|
5yr Avg Operating Profit Margin
|
6.78 % | 10.53 % | 26.94 % |
|
5 yr average Debt to Equity
|
-0.66 | 0.71 | 0.15 |
|
5yr CAGR Net Profit
|
n/a | 11.9 % | 13.86 % |
|
5yr Average Return on Assets
|
-4.27 % | 3.98 % | 15.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.8 % | 61.01 % | 18.97 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
61.8 % | 0.0 | -0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -3.05 % | -1.64 % |
|
Fischer Medical
|
India Glycols
|
GHCL
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|